FDA, Rare
Digest more
St. Louis Families Unite for Rare Disease Day 2026 as Take Part Foundation Advances Critical Genetic Testing and ...
The framework, first introduced by FDA Commissioner Marty Makary and Center for Biologics Evaluation and Research head Vinay ...
The Food and Drug Administration aims to evaluate treatments for rare diseases based on plausible evidence that they would work — without requiring a clinical trial first.
Scientific advances and cutting-edge technologies are reshaping how rare diseases are diagnosed and treated, bringing new hope to millions of patients and families. On Thursday, Feb. 24, Washington ...
Rare diseases are complex medical disorders that are notoriously difficult to diagnose because many present with a wide variety of symptoms that can overlap with more common illnesses. Currently, ...
“Working in rare diseases since 1996 has shown us that innovation is never a solo effort,” emphasized Melissa Fellner, Vice ...
Attention has turned to progressive supranuclear palsy, a rare neurodegenerative disorder. Here's what it is and why it's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results